Manic Symptoms and Behavioral Dysregulation in Youth with Velocardiofacial Syndrome (22q11.2 Deletion Syndrome). by Aneja, Alka et al.
Sacred Heart University
DigitalCommons@SHU
Speech-Language Pathology Faculty Publications Speech-Language Pathology
3-2007
Manic Symptoms and Behavioral Dysregulation in
Youth with Velocardiofacial Syndrome (22q11.2
Deletion Syndrome).
Alka Aneja
Wanda Fremont
Kevin M. Antshel
Stephen V. Faraone
Nuria AbdulSabur
See next page for additional authors
Follow this and additional works at: http://digitalcommons.sacredheart.edu/speech_fac
Part of the Congenital, Hereditary, and Neonatal Diseases and Abnormalities Commons, and the
Speech Pathology and Audiology Commons
This Peer-Reviewed Article is brought to you for free and open access by the Speech-Language Pathology at DigitalCommons@SHU. It has been
accepted for inclusion in Speech-Language Pathology Faculty Publications by an authorized administrator of DigitalCommons@SHU. For more
information, please contact ferribyp@sacredheart.edu, lysobeyb@sacredheart.edu.
Recommended Citation
Aneja, A., et al. "Manic Symptoms and Behavioral Dysregulation in Youth with Velocardiofacial Syndrome (22q11.2 Deletion
Syndrome)." Journal of Child and Adolescent Psychopharmacology 17.1 (2007): 105-114.
Authors
Alka Aneja, Wanda Fremont, Kevin M. Antshel, Stephen V. Faraone, Nuria AbdulSabur, Anne Marie Higgins,
Robert J. Shprintzen, and Wendy R. Kates
This peer-reviewed article is available at DigitalCommons@SHU: http://digitalcommons.sacredheart.edu/speech_fac/98
Manic Symptoms and Behavioral Dysregulation in
Youth with Velocardiofacial Syndrome 
(22q11.2 Deletion Syndrome)
Alka Aneja, M.D.,1 Wanda P. Fremont, M.D.,1 Kevin M. Antshel, Ph.D.,1 Stephen V.
Faraone, Ph.D.,1 Nuria AbdulSabur, B.A.,1 Anne Marie Higgins, N.P.,2 Robert
Shprintzen, Ph.D.,2 and Wendy R. Kates, Ph.D.1,3,4
ABSTRACT
Mania and bipolar disorder have been reported in adolescents and adults with velocardiofacial
syndrome (VCFS; also known as 22q11.2 deletion syndrome). Children with VCFS have a high
prevalence of attention-deficit/hyperactivity disorder (ADHD), which may constitute a risk fac-
tor for the eventual development of bipolar disorder in this population. Therefore, we sought to
determine whether children with VCFS exhibit more manic symptoms than community controls
that also may have learning disorders and ADHD. The study population consisted of 86 children
with VCFS and 36 community controls from ages 9 to 15 years, using measures of Young Mania
Rating Scale–Parent Version, Schedule for Affective Disorders and Schizophrenia for School-
Age Children–Present and Lifetime Version (K-SADS-PL), Child Behavior Checklist (CBCL),
and Wechsler Intelligence Scale for Children–3rd edition (WISC-III). The results indicate that
manic symptoms were not more prevalent in VCFS than in a community sample of children
with learning disorders and ADHD. However, after accounting for symptoms of depression and
ADHD, we found that manic symptoms in VCFS predicted uniquely to scores on four Child Be-
havior Checklist (CBCL) subscales, including anxiety, somatization, thought, and conduct prob-
lems. In contrast, manic symptoms in controls predicted uniquely to conduct problems only.
Accordingly, our findings of severe behavioral impairment in youth with VCFS and manic
symptoms suggest that these children may warrant more intensive monitoring and treatment
relative to youth with VCFS and ADHD only.
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INTRODUCTION
VELOCARDIOFACIAL SYNDROME (VCFS), alsoknown as 22q11.2 deletion syndrome, Di-
George syndrome, and conotruncal anomalies
face syndrome, is a multiple anomaly disorder
that is caused by a microdeletion of DNA from
chromosome 22 at the q11.2 band (Driscoll et al.
1992). Individuals with VCFS exhibit a highly
variable phenotype (Robin and Shprintzen
2005). Physical phenotypes include palate,
heart, renal, vascular, limb, brain, spine, and
immunologic anomalies (Robin and Shprintzen
2005). Language and motor delay occur in
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nearly all cases (Shprintzen 2000). Mild mental
retardation, persistent coordination deficits, and
poor academic performance are also common.
The deletion at chromosome 22q11.2 is also as-
sociated with a high frequency of behavioral
disorders during childhood, including attention-
deficit/hyperactivity disorder (ADHD), specific
phobias, and major depressive disorder (MDD;
Goldberg et al. 1993; Pulver et al. 1994; Karayior-
gou et al. 1995; Papolos et al. 1996; McCandless
et al. 1998; Gothelf et al. 1999; Arnold et al.
2001; Feinstein et al. 2002; Antshel et al. 2006).
There is some evidence, however, to suggest
that the prevalence rates of several of these
psychiatric disorders in children with VCFS do
not differ significantly from cognitively matched
samples (Feinstein et al. 2002).
As children with VCFS move into adulthood,
several groups report high rates of schizophre-
nia (Murphy and Owen 1997; Bassett et al. 1999;
Murphy et al. 1999; Arnold et al. 2001; Pinquier
et al. 2001; Feinstein et al. 2002). Less commonly
reported is bipolar mood disorder (Papolos et al.
1996). Despite relatively few research reports of
bipolar disorder in adults with VCFS, however,
we are aware of many anecdotal reports of
mania and bipolar disorder in children with
VCFS. This discrepancy might be due to the
natural course of VCFS psychiatric phenotype.
In fact, the oldest patients in the study by
Papolos and colleagues had schizophrenia and
schizoaffective disorder, suggesting that the
nature and course of psychiatric illness in VCFS
patients is still not clear (Papolos et al. 1996).
Papolos and colleagues found that 64% of
patients with VCFS met Diagnostic and Statisti-
cal Manual for Mental Disorders, 3rd edition,
revised (DSM-III-R; American Psychiatric
Association 1987) criteria for a spectrum of
bipolar disorders with full syndromal onset in
late childhood or early adolescence [mean age
of onset  12 years, standard deviation (SD)  3]
(Papolos et al. 1996). In addition, 20% of chil-
dren with bipolar disorder met DSM-III-R
criteria for ADHD, whereas 16% met criteria
for DSM-III-R attention-deficit disorder with-
out hyperactivity. These findings suggest an
unusually strong association between VCFS
and early-onset bipolar disorder. The high co-
morbidity between ADHD and bipolar disorder
is consistent with other studies of bipolar youth
(Biederman et al. 1996) and the familial associa-
tion between the two disorders (Faraone et al.
2003; Faraone and Tsuang 2003).
As noted above, the most common psychi-
atric co-morbidity in children and adolescents
with VCFS is ADHD as found in 35–55% of the
cohort (Papolos et al. 1996; Arnold et al. 2001;
Feinstein et al. 2002; Antshel et al. 2006). In light
of the high incidence of ADHD in VCFS, the fre-
quent association between ADHD and bipolar
disorder, and the potential risk for early onset
bipolar disorder in children with VCFS, we
were interested in whether children with VCFS
exhibit manic symptoms to a greater extent
than typically developing controls, and whether
manic symptoms in children with VCFS was
associated with a distinctive behavioral pheno-
type relative to our control sample.
There have been few systematic studies of
the overlap between ADHD and bipolar disor-
der due to the prevailing skepticism about the
very existence of childhood bipolar disease
(Goodwin and Jamison 1990) and the clinical
difficulties in distinguishing ADHD from
mania in children due, in part, to the overlap
in symptoms (Carlson 1984) and to the finding
that childhood mania may present differently
from its adult counterpart (Davis 1979;
McGlashan 1988; Biederman et al. 1995). None-
theless, Biederman and colleagues (1995)
described a Child Behavior Checklist Pediatric
Bipolar Disorder (CBCL-PBD) profile that dis-
criminated children with bipolar disorder
(many of whom also had ADHD) from ADHD
children who did not have bipolar disorder.
The profile accurately discriminated bipolar
from nonbipolar children (Faraone et al. 2005).
Similarly, other investigators have found that
the CBCL separates bipolar from ADHD
groups (Geller et al. 1998; Hazell et al. 1999).
Insofar as these findings suggest that child-
hood mania is distinguishable from childhood
ADHD, the present work sought to investigate
the extent to which manic symptoms accounted
for behavioral problems after accounting for the
effects of symptoms of ADHD and depression.
On the basis of this prior literature, we tested
two hypotheses: (1) Children with VCFS would
display more manic symptoms than commu-
nity controls, and (2) in children with VCFS
(but not necessarily community controls), after
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accounting for the variance explained by symp-
toms of ADHD and depression, the presence of
manic symptoms (based on the Young Mania
Rating Scale–Parent Version), would account
for a significant portion of variance in scores on
the Anxiety, Social Problems, Thought Prob-
lems, and Aggression subscales of the CBCL.
METHODS
Participants
The study population consisted of 86 children
with VCFS (39 females; mean age  11.9, SD 
2.1) and 36 community controls (12 females;
mean age  12.0; SD  1.9). All children ranged
in age from 9 to 15 years. Children with VCFS
were recruited from the Center for the Diagno-
sis, Treatment, and Study of VCFS at SUNY–
Upstate Medical University. All children with
VCFS had a fluorescent in situ hybridization
(FISH)-confirmed deletion in the chromosome
22q11.2 region. Community controls were
recruited from a local public school district.
Because children with VCFS exhibit learning
disabilities and ADHD, we did not exclude the
presence of either learning disabilities (LD) or
ADHD from our control sample. In addition, we
specifically excluded children whose parents re-
ported were in gifted classes, earned all “As”, or
read before the age of five. This resulted in a con-
trol sample in which LD and ADHD were over-
represented relative to the general population.
We reasoned that this strategy would enable us
to account for variance due to LD/ADHD in
general as opposed to variance due to VCFS per
se. Children with an identifiable neurological
condition other than VCFS (e.g., traumatic brain
injury, seizure disorder, birth weight below 2,500
grams as reported by parent) that is known to af-
fect cognitive or neuropsychiatric function were
excluded from participation from both groups.
Informed consent/assent was obtained from
parents and children under protocols approved
by the institutional review board.
Measures
Young Mania Rating Scale–Parent Version
(YMRS): This is an 11-item scale in a Likert-
scale format. Items describe symptoms that
are generally associated with mania, and par-
ents are asked to choose the most appropri-
ate description of their child. Comparisons
between parent ratings on this scale and clin-
ical ratings based on standard psychiatric in-
terviews indicate that the scale has adequate
discriminative validity (Gracious et al. 2002).
We used the summary score of the YMRS-P
as a continuous variable in our statistical
analyses.
Schedule for Affective Disorders and Schizophrenia
for School-Age Children–Present and Lifetime Ver-
sion (K-SADS-PL): The K-SADS-PL is a semi-
structured diagnostic interview schedule that
provides Diagnostic of Statistical Manual of Men-
tal Disorders, 4th edition (DSM-IV; American
Psychiatric Association 1994) psychiatric diag-
noses, based on interviews with the child’s pri-
mary caregiver (almost always his/her mother)
and the child (Kaufman et al. 1997). Although
we made every attempt to interview the child
as well as the parent, the child often had diffi-
culty responding; in these cases, the K-SADS-PL
data was based on the parent’s response. A child
psychiatrist or clinical child psychologist ad-
ministered the K-SADS-PL. Interrater reliabil-
ity, based on 12 interviews, was calculated with
the kappa coefficient, and was 0.91. The psy-
chiatric status of this sample, based on the
analysis of the K-SADS-PL, has been described
in Antshel et al. (2006).
For the current report, we used K-SADS-PL
responses to develop dimensional scores for
depression and ADHD, which we entered into
our regression model. The K-SADS-PL consists
of both an extensive screening module and
five supplemental modules. The screening
module contains DSM-IV symptoms for each
specific diagnostic category. The interviewer
assigns scores for each symptom, indicating
whether the symptom is present, absent, or
present but at the subthreshold level. Gener-
ally, subthreshold symptoms are assigned
when the child is experiencing the symptom,
but at a less frequent or less intense level than
would warrant a threshold-level score. Be-
cause many children with VCFS are at risk for
psychiatric disorders, but are not necessarily
exhibiting all the symptoms that would war-
rant a definite diagnosis, we were interested in
identifying children whose parents reported
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either subthreshold- or threshold-level symp-
toms of depression or ADHD.
We used the depression and the ADHD
screening modules to develop dimensional
scores based on this instrument. For each screen-
ing module, we assigned scores of 1 for each
symptom item that was not present; scores of 2
for each subthreshold-level symptom that was
endorsed, and scores of 3 for each threshold-
level symptom that was endorsed. Then we
summed all the scores, thereby deriving a di-
mensional score for depression and for ADHD.
These scores were entered into our regression
model, as described below.
Child Behavior Checklist (CBCL): Parents were
asked to complete the CBCL, a widely used
and reliable scale consisting of 113 items
(Achenbach 1991). We compared subscale scores
and a CBCL-PBD score between study groups.
To derive the CBCL-PBD scores, following the
guidelines of Faraone and colleagues (2005), we
summed the scaled scores for anxiety, depres-
sion, attention and aggression.
Wechsler Intelligence Scale for Children–3rd edi-
tion (WISC-III): The WISC-III is comprised of 13
subtests (Wechsler 1991). The current analyses
only utilized the general measure of intellectual
functioning, the Full Scale IQ (FSIQ).
Wechsler Individual Achievement Test–2nd edi-
tion (WIAT-II): The WIAT-II (Wechsler 2001) is
an individually administered test of academic
achievement, which has been standardized with
4,252 children in grades K–12. This test contains
nine subtests, which are aggregated into four
composite scores: Reading, mathematics, lan-
guage, writing, and an omnibus total score (M 
100, SD  15). For the present analyses, only the
total scores were used. These total scores were
used to operationalize a learning disability. A
designation of learning disability was based on a
1.5 S.D. discrepancy between the FSIQ of the
WISC-III and the WIAT-II total score or a WIAT-II
total score of  85.
Statistical analyses
Univariate and Chi-square analyses were
conducted to compare the study groups on
intelligence quotient (IQ) scores, gender ratio,
socioeconomic status (SES), and presence of
learning disabilities. Univariate analyses were
conducted to determine if study groups dif-
fered in scores on the YMRS-P and the CBCL-
PBD profile. A multivariate analysis of
variance (MANOVA) was conducted to com-
pare CBCL subscale scores between partici-
pants with VCFS and controls. A stepwise
regression model was used to determine the
degree to which manic symptoms (based on
the summary score of the YMRS-P) were pre-
dictive of subscale scores on the CBCL, after
controlling for the variance accounted for by
the presence of symptoms of depression and
ADHD (based on K-SADS dimensional scores).
The three predictors (symptoms of mania,
depression, and ADHD) were entered into the
model as a block, using the stepwise command.
(Prior to the regression analyses, initial linear
regressions were conducted to determine the
extent to which FSIQ, SES, and age were signifi-
cant predictors of CBCL subscale scores. The
significant predictors were entered as the first
step in the stepwise regression model.)
RESULTS
As shown in Table 1, study groups did not
differ in either age [F(1, 121)  0.022; p  0.88,
or gender-ratios, 2  1.51; p  0.22]. Socioeco-
nomic status was significantly lower in the
control group [F(1, 99)  4.39; p  0.04], and
FSIQ was significantly lower in the children
with VCFS [F(1, 121)  84.21; p  0.001, 2 
0.41]. As noted above, K-SADS-PL–based di-
agnoses of study participants have been de-
scribed elsewhere.
The omnibus MANOVA on the CBCL scales
was significant [Wilks   0.765, F(11, 103) 
2.87, p  0.002, 2  0.24]. Follow-up univari-
ate analyses revealed that the two groups dif-
fered on several CBCL subscales, including
Somatic Complaints [F(1, 120)  5.63, p  0.019,
2  0.05], Social Problems [F(1, 120)  11.58, p
 0.001, 2  0.09], Thought Problems [F(1, 120)
 6.56, p  0.012, 2  0.06]. Across all sub-
scales, parents of children with VCFS rated their
child as having more behavioral difficulties.
(See Table 1 for complete group mean scores.)
Because the study groups differed in SES
and FSIQ, both variables were entered as co-
variates in the analysis of group differences in
108 ANEJA ET AL.
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TABLE 1. DESCRIPTIVE DATA
VCFS Control
(n  86) (n  36)
Age 11.9 (2.1) 11.9 (1.9)
Sex (%male) 55 67
Socioeconomic status 47.5 (12.5)a 41.6 (13.8)
Participants taking 34 31
medication (%)
Antidepressants 4.6 5.5
(% of sample)
Mood stabilizers 6.0 5.5
Stimulants/atomoxetine 18.6 19.4
Atypical antipsychotics 3.4 0
WISC-III Full Scale IQ 70.5 (13.2)b 94.8 (13.7)
Incidence of learning 63 (75%)b 14 (37.8%)
disabilities
YMRS Summary Score 8.0 (8.1) 7.0 (6.1)
CBCL Anxiety T score 60.8 (8.8) 58.9 (8.8)
CBCL Depression T score 61.9 (9.0) 59.7 (11.3)
CBCL Somatic Complaints 62.2 (9.6)c 57.7 (8.7)
T score
CBCL Social Problems 65.9 (9.2)b 59.4 (10.1)
T score
CBCL Thought Problems 63.4 (9.4)a 58.6 (8.9)
T score
CBCL Attention Problems 65.9 (8.9) 62.8 (12.4)
T score
CBCL Rule-Breaking 57.3 (7.1) 54.7 (7.0)
T score
CBCL Aggression 60.0 (9.6) 56.9 (8.3)
T score
CBCL Internalizing 62.6 (10.0)c 56.0 (14.0)
T score
CBCL Externalizing 57.7 (9.7)a 53.0 (9.9)
T score
CBCL Total T score 63.7 (8.4)b 56.8 (11.8)
Socioeconomic status was measured by the Hollingshead
(1975) scale.
VCFS  Velocardiofacial syndrome; WISC-III  Wechsler
Intelligence Scale for Children–3rd edition (Wechsler, 1991);
YMRS  Young Mania Rating Scale–Parent Version
(Gracious et al., 2002); CBCL  Child Behavior Checklist
(Achenbach, 1991).
ap  0.05.
bp  0.001.
cp  0.01.
YMRS-P scores. This analysis indicated that
groups did not differ in number of manic
symptoms, on the basis of scores on the YMRS-
P [F(1, 113)  0.09; p  0.77; 2  0.01]. Simi-
larly, although scores on the CBCL-PBD profile
tended to be higher for the VCFS sample than
those of controls [F(1,113)  3.08; p  0.08; 2 
0.03], differences were negligible once SES and
FSIQ were entered as co-variates [F(1,113) 
0.00; p  1.0].
The results of stepwise regression analyses on
CBCL subscale scores are reported in Tables 2
and 3. Prior to conducting stepwise regression
analyses, simple linear regressions were con-
ducted to determine the extent to which FSIQ,
SES, and age were significant predictors of CBCL
subscale scores. SES was not a significant predic-
tor of CBCL scores for either group. Age was a
significant predictor of depression in children
with VCFS, but not controls. FSIQ was a signifi-
cant predictor of social and thought problems in
controls, but not in children with VCFS. Accord-
ingly, for children with VCFS, age was entered in
the first block of predictors of CBCL–Depression.
Similarly, for controls, FSIQ was entered in the
first block of predictors of CBCL–Social Prob-
lems and CBCL–Thought Problems.
In children with VCFS, the presence of
manic symptoms was the only significant pre-
dictor of CBCL subscale scores on anxiety (ac-
counting for 9.5% of the variance), somatization
(10%), thought problems (23%), and rule break-
ing (23%). Both manic and ADHD symptoms
were significant predictors of scores on social
problems (accounting for 21% and 8% of the
variance, respectively) and attention (11% and
12.7% of variance, respectively). Manic, ADHD,
and depression symptoms all were significant
predictors of scores on aggression. Manic symp-
toms accounted for over 30% of the variance in
scores on aggression. Depression and ADHD
symptoms accounted for only 5% and 4% of the
variance, respectively.
In our sample of community controls, the
presence of manic symptoms was the only sig-
nificant predictor of CBCL subscale scores rule
breaking (accounting for 20%). FSIQ and manic
symptoms were predictors of scores on social
problems, accounting for 15% and 11% of the
variance, respectively. Both manic and ADHD
symptoms were significant predictors of scores
on anxiety (accounting for 21% and 11% of the
variance, respectively). Both manic and depres-
sion symptoms were significant predictors of
somatization (accounting for 9% and 24% of the
variance, respectively) and aggression (31% and
13% of variance, respectively). FSIQ as well as
manic, ADHD, and depression symptoms were
significant predictors of scores on thought
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problems, accounting for 32%, 22%, 14%, and
8% of the variance, respectively. Complete re-
gression results can be seen in Tables 2 and 3.
Because age was a significant predictor of
depression in our group of youth with VCFS,
we conducted a follow-up logistic regression
analysis in which presence or absence of
depression (based on the K-SADS-PL) was
entered as the outcome variable, and Study
Group, Age, and Study Group  Age were en-
tered as the predictors. The overall significance
of the model was calculated with the Wald
statistic, which was significant (52.5; p  0.000).
The Study Group  Age interaction variable
was the only significant predictor (Wald statis-
tic, 4.9; p  0.027), indicating that older chil-
dren with VCFS, but not older controls, had a
higher incidence of depression.
DISCUSSION
In this sizeable sample of youth with VCFS,
we found that relative to controls, VCFS
participants were rated as having signifi-
cantly elevated scores on the CBCL subscales of
110 ANEJA ET AL.
TABLE 2. SIGNIFICANT PREDICTORS OF CBCL SUBSCALES IN VCFS SAMPLE FROM SCORES ON YMRS AND DIMENSIONAL
SCORES OF DEPRESSION AND ADHD FROM K-SADS-PL
Subscales Age/symptom predictors Beta T score P value R2 change
Anxiety Mania 0.31 2.77 0.007 0.095
Depression Age 0.25 2.22 0.03 0.161
Depression 0.32 2.80 0.007 0.082
Somatization Mania 0.32 2.86 0.006 0.101
Social Problems Mania 0.45 4.59 0.000 0.213
ADHD 0.29 2.91 0.005 0.083
Thought Problems Mania 0.48 4.70 0.000 0.232
Attention ADHD 0.35 3.39 0.001 0.127
Mania 0.34 3.27 0.002 0.113
Rule Breaking Mania 0.48 4.71 0.000 0.233
Aggression Mania 0.45 4.45 0.000 0.305
Depression 0.24 2.31 0.024 0.052
ADHD 0.19 2.04 0.045 0.036
CBCL  Child Behavior Checklist; VCFS  velocardiofacial syndrome; YMRS  Young Mania Rating Scale–Parent
Version; ADHD  Attention-deficit/hyperactivity disorder; K-SADS-PL  Schedule for Affective Disorders and
Schizophrenia for School-Age Children–Present and Lifetime Version.
TABLE 3. SIGNIFICANT PREDICTORS OF CBCL SUBSCALES IN CONTROL SAMPLE FROM SCORES ON YMRS AND DIMENSIONAL
SCORES OF DEPRESSION AND ADHD FROM K-SADS-PL
Subscales Age/symptom predictors Beta T score P value R2 change
Anxiety Mania 0.38 2.51 0.017 0.206
ADHD 0.35 2.27 0.03 0.114
Depression Depression 0.42 2.65 0.012 0.180
Somatization Depression 0.42 2.78 0.009 0.242
Mania 0.32 2.09 0.045 0.094
Social Problems Mania 0.36 2.17 0.038 0.112
Thought Problems FSIQ 0.35 3.50 0.002 0.320
ADHD 0.39 4.17 0.000 0.216
Depression 0.34 3.54 0.001 0.140
Mania 0.32 3.12 0.004 0.081
Attention ADHD 0.58 4.01 0.000 0.335
Rule Breaking Mania 0.45 2.85 0.007 0.203
Aggression Mania 0.47 3.45 0.002 0.316
CBCL  Child Behavior Checklist; YMRS  Young Mania Rating Scale–Parent Version; ADHD  attention-deficit/
hyperactivity disorder; K-SADS-PL  Schedule for Affective Disorders and Schizophrenia for School-Age Children–
Present and Lifetime Version.
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somatization, social problems, and thought
problems. Despite the anecdotal reports of
increased risk for manic symptoms in children
with VCFS, our data suggest that manic symp-
toms (as measured by both the YMRS-P and
the CBCL-PBD profile) do not appear to be
more prevalent in VCFS than in a community
sample of children with learning disorders
and ADHD. Moreover, with the exception of
thought problems and anxiety, manic symp-
toms appear to account for comparable
portions of the variance in behavioral prob-
lems across both VCFS and control samples.
However, in VCFS, the presence of manic
symptoms is the only predictor of scores on
four CBCL subscales. The presence of manic
symptoms alone results in increased levels of
anxiety, somatization, thought problems, and
conduct problems. In contrast, the presence
of manic symptoms in controls only predicts
uniquely to conduct problems (rule break-
ing). In addition, it is noteworthy that manic
symptoms in VCFS predict specifically to
scores on two of the three subscales (somati-
zation and thought problems) that are elevated
relative to controls.
This suggests that, in controls, depression
and ADHD symptoms must be present in con-
junction with manic symptoms to be predic-
tive of behavioral disturbance. This raises the
question of whether manic symptoms can be
reliably distinguished from ADHD symptoms
in individuals with nonsyndromic learning
disabilities. Co-morbidity between ADHD and
bipolar disorder has been noted frequently
(Wozniak 2005) in nonlearning–disabled sam-
ples. Although there is some overlap between
the diagnostic criterion sets for ADHD and
mania (e.g., distractibility), most of the diag-
nostic criteria do not overlap and some re-
search shows that the overlapping criteria
typically do not confound the diagnostic pro-
cess (Milberger et al. 1995). Clinicians must,
however, be careful not to confuse symptoms
of behavioral dysregulation or low tolerance
for frustration for manic symptoms; this can
be avoided by careful adherence to DSM-IV
criteria. Few studies have directly compared
the neuropsychological profile of youth with
bipolar disorder to those with ADHD (Doyle
et al. 2005). However, because executive
dysfunction is common to both groups
(Dickstein et al. 2004; Doyle et al. 2005; Seidman
2006), and is also present in many children
with learning disabilities (Gioia et al. 2002),
the task of distinguishing between manic
symptoms and ADHD symptoms may be par-
ticularly challenging in children with learning
disabilities.
In contrast to controls, the presence of manic
symptoms in children with VCFS places chil-
dren with this disorder at risk for behavioral
disturbance over and above the presence of
either depression symptoms or ADHD symp-
toms. This appears to be independent of the
positive relationship between depressive symp-
toms and age in youth with VCFS. Moreover,
the presence of manic symptoms in children
with VCFS is predictive of both internalizing
and externalizing disorders, suggesting that
manic symptoms result in greater overall be-
havioral dysregulation. In contrast, ADHD
symptoms do not predict to this degree of
behavioral dysregulation, suggesting that in
VCFS, manic symptoms may constitute a phe-
notype that is distinct from, and potentially
more severe than, an ADHD phenotype.
Because pervasive behavioral dysregulation
during childhood is associated with later psy-
chopathology (Verhulste and Van der Ende
1995; Biederman et al. 2001), our findings sug-
gest that the presence of manic symptoms in
children with VCFS may increase their vulner-
ability to continued psychiatric problems to a
greater extent than the presence of either
depression or ADHD symptoms.
VCFS is associated with intellectual delays;
epidemiological research suggests that psychi-
atric disorders are four to five times higher in
children with mental retardation compared to
typically developing children (Rutter et al.
1976; Koller et al. 1983). Nonetheless, these
data do not explain our interesting finding
that older children with VCFS, but not older
controls, had a higher incidence of depression.
The age association in VCFS may be related to
poor psychosocial adjustment and peer diffi-
culties; as children get older, they become in-
creasingly dependent on the peer group and
broader social milieu for learning about them-
selves and the world around them (Berndt
1996). Given that social difficulties are nearly
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ubiquitous in VCFS (Swillen et al. 1999; Prinzie
et al. 2002), it is possible that increasing social
difficulties during adolescence heighten the
risk for depressive symptoms. Future prospec-
tive research should address the extent to
which social difficulties presage the onset of
depressive symptoms in youth with VCFS.
These findings may have important clinical
implications for the treatment of children
with VCFS. Early assessment, diagnosis, and
treatment of manic symptoms is critical to
children with this disorder. It is essential that
clinicians consider and integrate the behav-
ioral and the neuropsychological correlates of
manic symptoms while formulating appro-
priate intervention strategies. Early identifi-
cation of manic symptoms in children with
VCFS, and provision of appropriate interven-
tions, may help to mitigate the relatively se-
vere emotional and behavioral dysregulation
that appears to accompany manic symptoms
in children with this disorder. Hence, future
psychosocial development may be enhanced
and further psychiatric deterioration poten-
tially minimized.
Our interpretation of these data is tem-
pered, however, by the finding that, although
manic symptoms are unique predictors of
several CBCL subscales in children with
VCFS, the overall predictive power of the
model is not as strong for children with VCFS
as for controls. For example, although the
presence of manic symptoms is uniquely as-
sociated with thought problems on the CBCL
in children with VCFS, it accounts for only
23% of the overall variance in thought prob-
lem scores. In contrast, in controls, the combi-
nation of FSIQ and symptoms of depression,
ADHD, and mania account for 76% of the
overall variance in thought problem scores.
Similarly, whereas mania is the unique pre-
dictor of anxiety scores in children with
VCFS, accounting for 10% of the total vari-
ance, the combination of symptoms of mania
and ADHD in controls accounts for 32% of
the overall variance in anxiety scores. This
pattern is similar for somatization scores as
well. This suggests that, although manic
symptoms increase vulnerability to anxiety,
somatization and thought problems in chil-
dren with VCFS to a greater extent than
symptoms of depression or ADHD, manic
symptoms still account for a smaller portion
of the variance than would be expected based
on our control sample. Moreover, our data
suggest that age and FSIQ are not contribut-
ing significantly to variance in CBCL scores in
children with VCFS. This raises the important
question of what is accounting for the rela-
tively severe behavioral phenotype (charac-
terized by increased levels of somatization,
social problems, and thought problems) that
children with VCFS exhibit relative to con-
trols. Several recent reports suggest that al-
lelic variation in the COMT gene, one copy of
which is deleted in VCFS, may be accounting
for the behavioral/psychiatric phenotype in
VCFS (Bearden et al. 2004; Bearden et al. 2005;
Gothelf et al. 2005). However, these findings
are inconsistent, and therefore additional
studies of genetic and environmental predic-
tors are warranted.
Despite this potential caveat, the children
in the current sample will be returning for
follow-up in 3 years. At that time, we will be
able to determine whether the natural course
of manic symptoms in children with this
disorder differs from controls. We will also
investigate whether the cluster of manic
symptoms, behavioral dysregulation, and ex-
ecutive dysfunction that a subset of our sam-
ple currently displays are associated with the
onset of more severe psychiatric disorder,
and, if so, what the nature of that disorder is.
Regardless of the nature of eventual risk,
however, our findings of the presence of rela-
tively severe behavioral impairment in youth
with VCFS and manic symptoms suggests
that this subset of children warrants careful
monitoring and treatment.
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